
Nippon India Pharma Fund - Direct Plan - Growth Plan
Add To Comparepreviously known as Reliance Pharma Dir Gr until
NAV on September 22, 2023
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
5,545 cr
Turnover Ratio
18.67%
Expense Ratio
1.01%
Exit Load
1.00%
if redeemed within
Returns
- 1M: -1.61%
- 1Y: 25.71%
- 3M: 11.83%
- 3Y: 15.96%
- 6M: 28.95%
- 5Y: 17.29%
Best Sector Healthcare Funds
NAME | LATEST NAV |
RETURNS 1y |
FUND ASSETS |
Expense RATIO |
RISK | |
25.240 | 26.39% | 3,174 cr | 1.21% | - |
Other plans of Nippon India Pharma